Company Celldex Therapeutics, Inc. Nasdaq
Equities
US15117B1035
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Novel Therapeutics
100.0
%
| 2 | 100.0 % | 7 | 100.0 % | +192.02% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 2 | 100.0 % | 7 | 100.0 % | +192.02% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Diane Young
CTO | Chief Tech/Sci/R&D Officer | 68 | 19-07-07 |
Chief Administrative Officer | 49 | 12-07-31 | |
Freddy Jimenez
LAW | General Counsel | 55 | 16-01-31 |
General Counsel | 67 | 17-10-02 | |
Richard Wright
PRN | Corporate Officer/Principal | 60 | 11-12-31 |
Corporate Officer/Principal | 52 | 08-12-31 | |
Ronald A. Pepin
PRN | Corporate Officer/Principal | 68 | 11-07-06 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
James Marino
BRD | Director/Board Member | 74 | 17-03-07 |
Chairman | 70 | 01-04-30 | |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Garry Neil
BRD | Director/Board Member | 70 | 22-06-15 |
Director/Board Member | 71 | 17-06-14 | |
Rita Jain
BRD | Director/Board Member | 62 | 23-02-15 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 64,403,377 | 65,686,894 ( 101.99 %) | 0 | 101.99 % |
Company contact information
Celldex Therapeutics, Inc.
Perryville III Building 53 Frontage Road
08827, Hampton
+908 200 7500
http://www.celldex.comSector
1st Jan change | Capi. | |
---|---|---|
+1.51% | 42.75B | |
+8.57% | 41.34B | |
+49.22% | 41.61B | |
-12.36% | 26.59B | |
+8.92% | 25.49B | |
-25.13% | 18.12B | |
+29.17% | 12.24B | |
-3.12% | 11.76B | |
+6.35% | 11B |